Obesity dipped slightly in U.S. adults last year, research found — the first time in more than a decade that the country has seen a downward trend. That might be due, in part, to the recent rise ...
Image: Adobe Stock SURMOUNT-OSA consisted of two phase 3 trials in which adults with obesity and moderate or severe OSA were randomly assigned to once-weekly tirzepatide or placebo for 1 year.
Ozempic is a medicine for adults with Type 2 diabetes that along with diet and exercise may improve blood sugar. Obesity dipped slightly in U.S. adults last year, research found — the first time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results